Bayer Suit Over Generic Yasmin Gets The Boot

A federal judge has ruled that Watson Pharmaceuticals Inc. and Sandoz Inc. won't infringe a Bayer AG patent by introducing a generic version of oral contraceptive Yasmin, saying the patent only...

Already a subscriber? Click here to view full article